Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 22, 1999Proceedings of the National Academy of SciencesOpen Access

Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: A phase I/II clinical trial

View Full Paper
Ask AI
Bookmark
Share

Authors

RNRobert B. NussenblattBrigham and Women's HospitalÉFÉric FortinUniversité de SherbrookeRSRhett M. SchiffmanNational Institutes of Health

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Nussenblatt et al. (1999) studied this question.

synapsesocial.com/papers/6aa3bad69fb7966fc9749404https://doi.org/10.1073/pnas.96.13.7462
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Biochemical and functional analysis of soluble human interleukin-2 receptor produced in rodent cells. Solid-phase reconstitution of a receptor-ligand binding reaction.1987 · 48 citations
  2. 2T cell lines mediating experimental autoimmune uveoretinitis (EAU) in the rat.1986 · 359 citations
  3. 3Interleukin-2–Receptor Blockade with Daclizumab to Prevent Acute Rejection in Renal Transplantation1998 · 878 citations
  4. 4Blockade of the interleukin-2 receptor by anti-Tac antibody: inhibition of human lymphocyte activation.1983 · 248 citations